n Obstetrics and Gynaecology Forum - Quality of life and gynaecological oncology : review

Volume 23, Issue 2
  • ISSN : 1027-9148



Biomedical endpoints such as overall survival and disease free survival are important outcome measures in the management of gynaecological malignancies. Curative treatment is associated with disease and treatment related morbidity. Quality of life assessment has become an integral part of management evaluation in both curative, but more so in palliative treatment scenarios. In specific situations quality of life has a direct effect on the choice of treatment option where biomedical outcome is equivalent in treatment arms. Quality of life outcomes determine preferred future treatment options. Quality of life assessments in ovarian, cervical, vulvar, endometrial cancer, and trophoblastic disease has a direct influence on future treatment options and also play a role in the support and management of long term survivors of the condition.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error